Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
6.93
+0.52 (8.11%)
At close: Jan 9, 2026, 4:00 PM EST
7.13
+0.20 (2.89%)
Pre-market: Jan 12, 2026, 8:08 AM EST
Alpha Tau Medical Market Cap
Alpha Tau Medical has a market cap or net worth of $590.88 million as of January 12, 2026. Its market cap has increased by 173.66% in one year.
Market Cap
590.88M
Enterprise Value
532.17M
1-Year Change
173.66%
Ranking
Category
Stock Price
$6.93
Market Cap Chart
Since March 8, 2021, Alpha Tau Medical's market cap has increased from $347.19M to $590.88M, an increase of 70.19%. That is a compound annual growth rate of 11.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 590.88M | 40.00% |
| Dec 31, 2025 | 422.06M | 94.21% |
| Dec 31, 2024 | 217.32M | 3.92% |
| Dec 29, 2023 | 209.12M | -4.71% |
| Dec 30, 2022 | 219.46M | -34.99% |
| Dec 31, 2021 | 337.56M | -2.77% |
| Mar 8, 2021 | 347.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |